CN116211984B - A Chinese medicinal composition eye ointment for preventing and treating myopia of children and teenagers, and its preparation method - Google Patents
A Chinese medicinal composition eye ointment for preventing and treating myopia of children and teenagers, and its preparation method Download PDFInfo
- Publication number
- CN116211984B CN116211984B CN202310245878.0A CN202310245878A CN116211984B CN 116211984 B CN116211984 B CN 116211984B CN 202310245878 A CN202310245878 A CN 202310245878A CN 116211984 B CN116211984 B CN 116211984B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- myopia
- children
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 73
- 208000001491 myopia Diseases 0.000 title claims abstract description 67
- 230000004379 myopia Effects 0.000 title claims abstract description 63
- 239000003885 eye ointment Substances 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 74
- 239000000463 material Substances 0.000 claims abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 25
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 8
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 6
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 6
- 235000013976 turmeric Nutrition 0.000 claims abstract description 6
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 4
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 4
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract description 4
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 4
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 4
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 4
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 4
- 241000675108 Citrus tangerina Species 0.000 claims abstract description 4
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 4
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 4
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 4
- 240000003705 Senecio vulgaris Species 0.000 claims abstract description 4
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 4
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 4
- 244000170916 Paeonia officinalis Species 0.000 claims abstract description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 49
- 238000002156 mixing Methods 0.000 claims description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 35
- 239000006071 cream Substances 0.000 claims description 28
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 claims description 24
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 20
- 239000002674 ointment Substances 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 12
- 229940095102 methyl benzoate Drugs 0.000 claims description 12
- 239000003871 white petrolatum Substances 0.000 claims description 12
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 11
- 235000021355 Stearic acid Nutrition 0.000 claims description 11
- 229940057995 liquid paraffin Drugs 0.000 claims description 11
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 11
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 11
- 239000004302 potassium sorbate Substances 0.000 claims description 11
- 229940069338 potassium sorbate Drugs 0.000 claims description 11
- 235000010241 potassium sorbate Nutrition 0.000 claims description 11
- 239000008117 stearic acid Substances 0.000 claims description 11
- 244000293323 Cosmos caudatus Species 0.000 claims description 10
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 9
- 229920000136 polysorbate Polymers 0.000 claims description 9
- 229960004274 stearic acid Drugs 0.000 claims description 9
- 241000213006 Angelica dahurica Species 0.000 claims description 4
- 235000014375 Curcuma Nutrition 0.000 claims description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 2
- -1 fructus Lycii Chemical compound 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims 5
- 241000208340 Araliaceae Species 0.000 claims 3
- 229940107666 astragalus root Drugs 0.000 claims 2
- HTUMBQDCCIXGCV-UHFFFAOYSA-N lead oxide Chemical compound [O-2].[Pb+2] HTUMBQDCCIXGCV-UHFFFAOYSA-N 0.000 claims 2
- YEXPOXQUZXUXJW-UHFFFAOYSA-N lead(II) oxide Inorganic materials [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 claims 2
- 239000002994 raw material Substances 0.000 claims 2
- 244000236658 Paeonia lactiflora Species 0.000 claims 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims 1
- 230000008506 pathogenesis Effects 0.000 abstract description 4
- 235000006533 astragalus Nutrition 0.000 abstract description 3
- 230000004069 differentiation Effects 0.000 abstract description 3
- 208000011580 syndromic disease Diseases 0.000 abstract description 3
- 241000045403 Astragalus propinquus Species 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000009194 climbing Effects 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 description 34
- 230000000694 effects Effects 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 11
- 240000004371 Panax ginseng Species 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 230000004438 eyesight Effects 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 241000700199 Cavia porcellus Species 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 241000700198 Cavia Species 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000004402 high myopia Effects 0.000 description 3
- 206010015958 Eye pain Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010052143 Ocular discomfort Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000002430 laser surgery Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004342 moderate myopia Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000014733 refractive error Diseases 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010725 Conjunctival irritation Diseases 0.000 description 1
- 208000020564 Eye injury Diseases 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000029091 Refraction disease Diseases 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 208000004350 Strabismus Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000004430 ametropia Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004423 myopia development Effects 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/241—Lead; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers and a preparation method thereof, which belong to the technical field of traditional Chinese medicine preparation, wherein the traditional Chinese medicine composition eye ointment is prepared from a traditional Chinese medicine mixture and auxiliary materials, and the traditional Chinese medicine mixture comprises the following components in parts by weight: 7-11 parts of astragalus membranaceus, 7-11 parts of ginseng, 4-8 parts of angelica sinensis, 4-8 parts of white paeony root, 4-8 parts of medlar, 4-8 parts of turmeric, 4-8 parts of wormwood, 2-4 parts of wild chrysanthemum flower, 2-4 parts of climbing groundsel herb, 2-4 parts of green tangerine peel, 2-4 parts of grassleaf sweelflag rhizome and 2-4 parts of pearl powder. The traditional Chinese medicine composition eye ointment is specific to the specific pathogenesis cause of the myopia of the teenagers of children, has full and specific syndrome differentiation, is low in price, convenient to use, safe and effective.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicine preparations, and in particular relates to traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers and a preparation method thereof.
Background
With the rapid development of social information networks, the ocular tension is increased in life, study and work of people, the learning of children and teenagers is heavy, the ocular time and intensity are increased greatly before, and thus the occurrence of myopia of children and teenagers is increased. Light and moderate myopia, poor vision, squinting, wearing glasses, which bring a plurality of inconveniences to the life, study, growth and industry selection of children; the high myopia of more than 600 degrees is accompanied with pathological changes of eyeground, such as retinal detachment and scleral grape swelling, so that the eyesight of children is seriously damaged, the blindness is dangerous, and the life quality of the children and teenagers is seriously affected.
Near vision is good, and far vision is blurred, so that people often squint eyes to see things and eye fatigue is easy. High myopia, prominent eye drops and severely reduced hyperopia. The pathogenesis of the myopia of the teenagers of children mainly comprises excessive use of eyes, consumption of body fluid by the eyes, channel obstruction, liver orifice by the eyes, liver injury caused by eye injury, kidney injury caused by long-term injury, and liver-kidney deficiency.
At present, methods for preventing and treating myopia include wearing glasses, laser surgery and the like. Besides the defect of treating the symptoms without treating the root causes, the laser surgery has potential side effects on eyes. The method for preventing and treating myopia in traditional Chinese medicine comprises acupuncture points, eye plaster, massage, etc. The traditional Chinese medicine of the eye ointment is insufficient in compatibility of medicines, is not specific, has a general formula and is used for all patients with ametropia including myopia. In fact, the myopia of the teenagers and the children has own specific pathogenesis, and the individual treatment based on syndrome differentiation and the individual prescription should be given.
At present, no traditional Chinese medicine prescription eye cream specially aiming at independent diagnosis and treatment of myopia of children and teenagers exists, and the invention can fill the gap. The eye ointment has unique formula, is safe and convenient to use, can effectively relieve the occurrence and development of myopia of children and teenagers, and can help children to have healthy eyesight.
Disclosure of Invention
The invention provides a traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers and a preparation method thereof.
In order to solve the problems, the invention adopts the following technical scheme.
A traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers is characterized by being prepared from a traditional Chinese medicine mixture and auxiliary materials in parts by weight:
44-82 parts of a traditional Chinese medicine mixture,
and 441-579 parts of auxiliary materials.
A traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers is prepared from a traditional Chinese medicine mixture and auxiliary materials in parts by weight:
63 parts of a Chinese medicinal mixture,
500 parts of auxiliary materials.
The traditional Chinese medicine mixture comprises the following components in parts by weight:
the traditional Chinese medicine mixture comprises the following components in parts by weight:
wherein, the auxiliary materials comprise the following components in parts by weight:
wherein, the auxiliary materials comprise the following components in parts by weight:
a preparation method of a traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers comprises the following steps:
(1) The Chinese medicinal composition is prepared by decocting the filtrate: mixing radix astragali, ginseng radix, radix Angelicae sinensis, radix Paeoniae alba, fructus Lycii, curcuma rhizome, folium Artemisiae Argyi, flos Chrysanthemi Indici, herba Senecionis Scandentis, pericarpium Citri Reticulatae viride, and rhizoma Acori Graminei, decocting in water for 2 times (1 hr each time), mixing decoctions, and filtering with 400 mesh sieve to obtain Chinese medicinal decoction;
(2) Preparing myopia ointment: mixing stearic acid, glyceryl monostearate, liquid paraffin and white vaseline to obtain an oil phase, mixing the Chinese medicinal decoction, triethanolamine, glycerol, tween, methyl benzoate and potassium sorbate to obtain water phase, respectively heating the oil phase and water phase to 85deg.C in water, slowly pouring the oil phase into the water phase, stirring to obtain cream with milky yellow and semisolid, cooling the cream to 55deg.C, adding Margarita powder and Lithargyrum powder, and stirring for 2 hr until the cream is condensed.
The application method of the myopia ointment formula comprises 3 times a day for 5 minutes each time. The eye ointment is applied on the periphery of the eye, and the index finger starts from the Ming acupoint of the eye of the eyebrow and goes from the upper orbit to the Tongziliao acupoint of the eyebrow, then goes to the temple, goes to the lower orbital margin, goes to the four-white acupoint, and finally goes to the inner canthus side of the inner side of the nose, and then is pressed, retracted and stopped by the index finger at the acupoint, and the acid distending pain is felt by itself.
Compared with the prior art, the invention has the beneficial effects that:
the monarch drugs in the invention are astragalus and ginseng, which are good drugs for invigorating qi and blood, and have definite effect and mild effect. Teenagers are pure yang bodies, and the yin fluid is often insufficient, so that excessive eyes are easy to consume qi and consume body fluid, and the qi and blood are deficient, so that the meridians are retarded, and the eyes are unclear and the vision is far from clear. Astragalus mongholicus and ginseng are sweet in taste and slightly warm in nature, can tonify qi and raise yang,
promoting the production of body fluid, nourishing blood, promoting the circulation of qi, and relieving arthralgia. Can be used for treating myopia due to excessive use of eyes of teenagers and children. The two components are monarch drugs, and the dosage is the largest.
The excessive use of eyes causes the discomfort of the distant vision, the deficiency of qi and blood, which inevitably leads to the obstruction of the channels and collaterals around the eyes, which is the orifice of the liver, and the obstruction of the channels and collaterals around the eyes, which inevitably hurts the liver, and the deficiency of both the liver and the kidney. In the formula, the Chinese angelica and the white paeony root enrich the blood,
the medlar nourishes liver and kidney, the turmeric and the wormwood warm channels and unblock collaterals, and the medicines are ministerial medicines, and the dosage is slightly inferior to that of monarch medicines.
Overuse of the eyes causes qi stagnation and fluid impairment in the eyes, and liver and kidney deficiency, which often manifests as up-flaming of liver fire. In the formula, the wild chrysanthemum flower, the groundsel herb, the heat and the toxin are cleared, the fire is discharged, the liver is calmed and the eyesight is improved; pearl powder for suppressing hyperactive liver, subsiding yang, nourishing liver yin, and improving eyesight. Qing Pi, with the actions of activating qi and resolving stagnation, is good at Shu Ganyu. The four are adjuvant drugs with small dosage. The grassleaf sweelflag rhizome has the advantages of pungent and fragrant smell, bitter and dry taste, warmth and general, and mild action, is suitable for children and teenagers to refresh and restore consciousness, and is the drug with the minimum dosage.
The traditional Chinese medicine composition eye ointment provided by the invention aims at the specific pathogenesis cause of the myopia of the teenagers of children, has full and specific syndrome differentiation, is low in price, convenient to use, safe and effective.
Detailed Description
The technical solutions of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention, and it is apparent that the described embodiments are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
The invention is further described below in connection with specific embodiments.
Preparing articles:
1 stage of electronic balance;
1 stove;
1 pan;
2 beakers;
1 stage of stirrer;
2 thermometer at 100deg.C.
When the following examples are used to prepare the eye ointments of the Chinese medicinal composition, the following requirements are set:
1. ultraviolet lamp sterilization is needed for 2 hours in the manufacturing environment;
2. the container is manufactured by high-pressure sterilization;
3. the paste is stirred in the same direction so as to avoid whipping.
Example 1
The embodiment provides a traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers, which is prepared from a traditional Chinese medicine mixture and auxiliary materials, wherein the traditional Chinese medicine mixture comprises the following components in parts by weight:
wherein the auxiliary materials comprise the following components:
the preparation method of the traditional Chinese medicine composition eye ointment for preventing and treating the myopia of the teenagers and the children comprises the following steps:
(1) The Chinese medicinal composition is prepared by decocting the filtrate: mixing radix astragali, radix Ginseng, radix Angelicae sinensis, radix Paeoniae alba, fructus Lycii, rhizoma Curcumae Longae, folium Artemisiae Argyi, flos Chrysanthemi Indici, herba Senecionis Scandentis, pericarpium Citri Reticulatae viride, and rhizoma Acori Tatarinowii, decocting in 10 times of water for 2 times (1 hr each time), mixing decoctions, and filtering with 400 mesh sieve to obtain 1000ml decoction;
(2) Preparing myopia ointment: mixing stearic acid, glyceryl monostearate, liquid paraffin and white vaseline to obtain an oil phase, mixing the Chinese medicinal decoction, triethanolamine, glycerol, tween, methyl benzoate and potassium sorbate to obtain water phase, respectively heating the oil phase and water phase to 85deg.C in water, slowly pouring the oil phase into the water phase, stirring to obtain cream with milky yellow and semisolid, cooling the cream to 55deg.C, adding Margarita powder and Lithargyrum powder, and stirring for 2 hr until the cream is condensed.
Example 2
The embodiment provides a traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers, which is prepared from a traditional Chinese medicine mixture and auxiliary materials, wherein the traditional Chinese medicine mixture comprises the following components in parts by weight:
wherein the auxiliary materials comprise the following components:
the preparation method of the traditional Chinese medicine composition eye ointment for preventing and treating the myopia of the teenagers and the children comprises the following steps:
(1) The Chinese medicinal composition is prepared by decocting the filtrate: mixing radix astragali, radix Ginseng, radix Angelicae sinensis, radix Paeoniae alba, fructus Lycii, rhizoma Curcumae Longae, folium Artemisiae Argyi, flos Chrysanthemi Indici, herba Senecionis Scandentis, pericarpium Citri Reticulatae viride, and rhizoma Acori Tatarinowii, decocting in 10 times of water for 2 times (1 hr each time), mixing decoctions, and filtering with 400 mesh sieve to obtain 1000ml decoction;
(2) Preparing myopia ointment: mixing stearic acid, glyceryl monostearate, liquid paraffin and white vaseline to obtain an oil phase, mixing the Chinese medicinal decoction, triethanolamine, glycerol, tween, methyl benzoate and potassium sorbate to obtain water phase, respectively heating the oil phase and water phase to 85deg.C in water, slowly pouring the oil phase into the water phase, stirring to obtain cream with milky yellow and semisolid, cooling the cream to 55deg.C, adding Margarita powder and Lithargyrum powder, and stirring for 2 hr until the cream is condensed.
Example 3
The embodiment provides a traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers, which is prepared from a traditional Chinese medicine mixture and auxiliary materials, wherein the traditional Chinese medicine mixture comprises the following components in parts by weight:
wherein the auxiliary materials comprise the following components:
the preparation method of the traditional Chinese medicine composition eye ointment for preventing and treating the myopia of the teenagers and the children comprises the following steps:
(1) The Chinese medicinal composition is prepared by decocting the filtrate: mixing radix astragali, radix Ginseng, radix Angelicae sinensis, radix Paeoniae alba, fructus Lycii, rhizoma Curcumae Longae, folium Artemisiae Argyi, flos Chrysanthemi Indici, herba Senecionis Scandentis, pericarpium Citri Reticulatae viride, and rhizoma Acori Tatarinowii, decocting in 10 times of water for 2 times (1 hr each time), mixing decoctions, and filtering with 400 mesh sieve to obtain 1000ml decoction;
(2) Preparing myopia ointment: mixing stearic acid, glyceryl monostearate, liquid paraffin and white vaseline to obtain an oil phase, mixing the Chinese medicinal decoction, triethanolamine, glycerol, tween, methyl benzoate and potassium sorbate to obtain water phase, respectively heating the oil phase and water phase to 85deg.C in water, slowly pouring the oil phase into the water phase, stirring to obtain cream with milky yellow and semisolid, cooling the cream to 55deg.C, adding Margarita powder and Lithargyrum powder, and stirring for 2 hr until the cream is condensed.
Example 4
The embodiment provides a traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers, which is prepared from a traditional Chinese medicine mixture and auxiliary materials, wherein the traditional Chinese medicine mixture comprises the following components in parts by weight:
wherein the auxiliary materials comprise the following components:
the preparation method of the traditional Chinese medicine composition eye ointment for preventing and treating the myopia of the teenagers and the children comprises the following steps:
(1) The Chinese medicinal composition is prepared by decocting the filtrate: mixing radix astragali, radix Ginseng, radix Angelicae sinensis, radix Paeoniae alba, fructus Lycii, rhizoma Curcumae Longae, folium Artemisiae Argyi, flos Chrysanthemi Indici, herba Senecionis Scandentis, pericarpium Citri Reticulatae viride, and rhizoma Acori Tatarinowii, decocting in 10 times of water for 2 times (1 hr each time), mixing decoctions, and filtering with 400 mesh sieve to obtain 1000ml decoction;
(2) Preparing myopia ointment: mixing stearic acid, glyceryl monostearate, liquid paraffin and white vaseline to obtain an oil phase, mixing the Chinese medicinal decoction, triethanolamine, glycerol, tween, methyl benzoate and potassium sorbate to obtain water phase, respectively heating the oil phase and water phase to 85deg.C in water, slowly pouring the oil phase into the water phase, stirring to obtain cream with milky yellow and semisolid, cooling the cream to 55deg.C, adding Margarita powder and Lithargyrum powder, and stirring for 2 hr until the cream is condensed.
Example 5
The embodiment provides a traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers, which is prepared from a traditional Chinese medicine mixture and auxiliary materials, wherein the traditional Chinese medicine mixture comprises the following components in parts by weight:
wherein the auxiliary materials comprise the following components:
the preparation method of the traditional Chinese medicine composition eye ointment for preventing and treating the myopia of the teenagers and the children comprises the following steps:
(1) The Chinese medicinal composition is prepared by decocting the filtrate: mixing radix astragali, radix Ginseng, radix Angelicae sinensis, radix Paeoniae alba, fructus Lycii, rhizoma Curcumae Longae, folium Artemisiae Argyi, flos Chrysanthemi Indici, herba Senecionis Scandentis, pericarpium Citri Reticulatae viride, and rhizoma Acori Tatarinowii, decocting in 10 times of water for 2 times (1 hr each time), mixing decoctions, and filtering with 400 mesh sieve to obtain 1000ml decoction;
(2) Preparing myopia ointment: mixing stearic acid, glyceryl monostearate, liquid paraffin and white vaseline to obtain an oil phase, mixing the Chinese medicinal decoction, triethanolamine, glycerol, tween, methyl benzoate and potassium sorbate to obtain water phase, respectively heating the oil phase and water phase to 85deg.C in water, slowly pouring the oil phase into the water phase, stirring to obtain cream with milky yellow and semisolid, cooling the cream to 55deg.C, adding Margarita powder and Lithargyrum powder, and stirring for 2 hr until the cream is condensed.
Comparative example 1
The embodiment provides a traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers, which is prepared from a traditional Chinese medicine mixture and auxiliary materials, wherein the traditional Chinese medicine mixture comprises the following components in parts by weight:
in this example, compared with the traditional Chinese medicine composition of example 1, turmeric is replaced by ginger, and other components and formula amounts are the same.
Wherein the auxiliary materials comprise the following components:
the preparation method of the traditional Chinese medicine composition eye ointment for preventing and treating the myopia of the teenagers and the children comprises the following steps:
(1) The Chinese medicinal composition is prepared by decocting the filtrate: mixing radix astragali, radix Ginseng, radix Angelicae sinensis, radix Paeoniae alba, fructus Lycii, rhizoma Zingiberis recens, folium Artemisiae Argyi, flos Chrysanthemi Indici, herba Senecionis Scandentis, pericarpium Citri Reticulatae viride, and rhizoma Acori Tatarinowii, decocting in 10 times of water for 2 times (1 hr each time), mixing decoctions, and filtering with 400 mesh sieve to obtain 1000ml decoction;
(2) Preparing myopia ointment: mixing stearic acid, glyceryl monostearate, liquid paraffin and white vaseline to obtain an oil phase, mixing the Chinese medicinal decoction, triethanolamine, glycerol, tween, methyl benzoate and potassium sorbate to obtain water phase, respectively heating the oil phase and water phase to 85deg.C in water, slowly pouring the oil phase into the water phase, stirring to obtain cream with milky yellow and semisolid, cooling the cream to 55deg.C, adding Margarita powder and Lithargyrum powder, and stirring for 2 hr until the cream is condensed.
Comparative example 2
The embodiment provides a traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers, which is prepared from a traditional Chinese medicine mixture and auxiliary materials, wherein the traditional Chinese medicine mixture comprises the following components in parts by weight:
compared with the traditional Chinese medicine mixture in the embodiment 1, the traditional Chinese medicine mixture does not contain green tangerine peel, and other components and the formula amount are the same.
Wherein the auxiliary materials comprise the following components:
the preparation method of the traditional Chinese medicine composition eye ointment for preventing and treating the myopia of the teenagers and the children comprises the following steps:
(1) The Chinese medicinal composition is prepared by decocting the filtrate: mixing radix astragali, radix Ginseng, radix Angelicae sinensis, radix Paeoniae alba, fructus Lycii, rhizoma Curcumae Longae, folium Artemisiae Argyi, flos Chrysanthemi Indici, herba Senecionis Scandentis, margarita powder, and rhizoma Acori Tatarinowii, decocting in 10 times of water for 2 times (1 hr each time), mixing decoctions, and filtering with 400 mesh sieve to obtain 1000ml decoction;
(2) Preparing myopia ointment: mixing stearic acid, glyceryl monostearate, liquid paraffin and white vaseline to obtain an oil phase, mixing the Chinese medicinal decoction, triethanolamine, glycerol, tween, methyl benzoate and potassium sorbate to obtain water phase, respectively heating the oil phase and water phase to 85deg.C in water, slowly pouring the oil phase into the water phase, stirring to obtain cream with milky yellow and semisolid, cooling the cream to 55deg.C, adding Margarita powder and Lithargyrum powder, and stirring for 2 hr until the cream is condensed.
Animal toxicity test
1. Acute periocular skin allergy test:
10 healthy guinea pigs with the age of 3 months are selected, the weight is 450-700 g, and the male and female are half. The upper part of the guinea pig in the eyes was dehaired at about 1cm by 1cm in area 24 hours before administration. The myopia ointment of the example 1 is uniformly smeared on a dehairing area, the medical non-irritant adhesive tape is used for fixing and sealing for 24 hours, the adhesive tape and the eye ointment are removed after 24 hours, the skin and systemic poisoning signs of animals are observed, the observation period is 7 days, and the animals are sacrificed by a neck pulling method after the test is finished, so that the general pathology observation is carried out.
Test results: the test animals did not die during the test period, the activities were fed normally, and no abnormalities were seen in the whole body skin. Cadavers were generally necropsied, and no obvious abnormalities were seen in heart, liver, spleen, lung, kidney.
Conclusion: guinea pig has no acute skin anaphylaxis to tested eye ointment
2. Acute conjunctival irritation test
6 healthy guinea pigs with the age of 3 months are selected, the weight is 450-700 g, and the male and female are half. In the test, the water decoction of the traditional Chinese medicine composition obtained in the application is placed to normal temperature, and 1 drop of the water decoction is dripped into the left eye of each guinea pig after being sucked by a sterile dropper, and the right eye is used for comparison observation. 30min,1h,24h,48h,72h after dripping the test substance, and observing the conjunctival congestion of the eyes of the guinea pigs.
Test results: no ocular abnormalities were observed at each time point after instillation of the test article, and during the observation period, animals were fed normally with activity and no death.
Conclusion: the Chinese medicinal composition water decoction used in the application has no obvious irritation to guinea pig conjunctiva
Clinical data of myopia ointment
1. Case sources
Collecting 240 myopic teenager patients from a certain ophthalmic hospital in Zhengzhou city from 11 months 2021 to 4 months 2022.
2. Diagnostic criteria and classification
Diagnostic criteria are formulated with reference to diagnosis and classification criteria for myopia in Chinese ophthalmology. The diagnosis standard of myopia is a refractive error in which the eye forms a focus in front of the retina after parallel rays pass through the refractive system of the eye in a state of regulating relaxation, the far point moves closer, and the axial length of the eyeball is larger than the refractive power of the eyeball.
Classification of myopia extent:
1) Mild myopia: myopia of < -3.0D
2) Moderate myopia: myopia of-3.0D-6.0D
3) High myopia: myopia of > -6.0D
3. Exclusion criteria
1) Is not in compliance with the above diagnostic and inclusion criteria
2) Patients with other eye diseases and have influence on curative effect determination
3) Patients with other systemic diseases and mental diseases
4) Those undergoing other treatment methods
4. Grouping and treatment method
240 patients which are taken into observation are randomly divided into four groups according to the order of clinic visits, and all cases are completed in the whole process without falling cases. Before treatment, the comparison between the two groups of examination results has no statistical difference, and the data has comparability. Wherein, 60 cases of treatment group 1 are treated, the myopia ointment of the embodiment 1 of the invention is applied for 3 times per day in the observation period; treatment of 60 cases in treatment group 2, treatment with the myopia ointment of comparative example 1 of the present invention was applied 3 times daily over the observation period; treatment of 3 groups of 60 cases, treatment with the inventive comparative example 2 myopic eye ointment was applied 3 times daily over the observation period; treatment of 4 groups 60 cases, administration of cool compress gel with bosom and eye moistening effects, and application of cool compress gel with eye moistening effect was performed 3 times daily during observation period. After 2 months, the two groups of cases are subjected to index detection, and the curative effect is observed.
5. Effect determination
The use effect is divided into effective and ineffective.
The method is effective: the original subjective visual discomfort, such as blurred vision, eye soreness, eye distension, eye pain, headache and the like, disappears; or the wearing mirror power is reduced by more than 50 degrees; or the naked eyes are far away, and the near vision is improved by more than 0.1 compared with the prior art. Any one of the above steps is effective.
Invalidation: subjective visual discomfort such as blurred vision, eye soreness, eye distension, eye pain, headache, etc. still exists; or the lens wearing degree is unchanged; or the wearing power is deepened more forward; or the naked eyes are far away, and the near vision is not improved; or the naked eyes are far away, and the near vision is reduced by more than 0.1 compared with the front.
6. Statistical method
SPSS17.0 software was used for data processing. The pre-and post-treatment metering data of each group adopts paired t test, the comparison among groups adopts variance analysis, the test level a=0.05, and the difference is statistically significant when p is less than 0.05.
7. Observation result
Group of | Eye ointment name | Case (personal) | Effective and effective | Invalidation of | Effective rate of |
Treatment group 1 | Myopia ointment | 60 | 57 | 3 | 95.0% |
Treatment group 2 | Myopia ointment | 60 | 54 | 6 | 90.0% |
Treatment 3 groups | Myopia ointment | 60 | 51 | 9 | 85.0% |
Treatment 4 groups | Eye-moistening cold compress gel | 60 | 52 | 8 | 86.7% |
8. Conclusion(s)
The observation results show that the treatment of the group 1 and the treatment of the group 2 can improve the clinical symptoms of teenager myopia patients, and compared with the eye-moistening cold compress gel, the myopia ointment has more remarkable curative effect. And the eye pastes of comparative example 1 and comparative example 2 were significantly lower in efficacy than the eye paste of example 1.
The foregoing is a further elaboration of the present invention in connection with the detailed description, and it is not intended that the invention be limited to the specific embodiments shown, but rather that a number of simple deductions or substitutions be made by one of ordinary skill in the art without departing from the spirit of the invention, should be considered as falling within the scope of the invention as defined in the appended claims.
Claims (5)
1. A traditional Chinese medicine composition eye ointment for preventing and treating myopia of children and teenagers is characterized by being prepared from a traditional Chinese medicine mixture and auxiliary materials in parts by weight:
44-82 parts of a traditional Chinese medicine mixture,
441-579 parts of auxiliary materials;
the traditional Chinese medicine mixture comprises the following raw materials in parts by weight:
7-11 parts of astragalus root,
7-11 parts of ginseng and the like,
4-8 parts of Chinese angelica,
4-8 parts of white peony root,
4-8 parts of medlar, which are mixed together,
4-8 parts of turmeric, namely,
4-8 parts of wormwood,
2-4 parts of wild chrysanthemum flower,
2-4 parts of groundsel herb,
2-4 parts of green tangerine peel,
2-4 parts of grassleaf sweelflag rhizome,
2-4 parts of pearl powder;
the auxiliary materials comprise the following components in parts by weight:
90-110 parts of stearic acid,
40-60 parts of glycerin monostearate,
40-60 parts of liquid paraffin,
90-110 parts of white vaseline,
40-60 parts of triethanolamine, wherein the triethanolamine comprises the following components,
90-110 parts of glycerin, and the balance of glycerin,
5-15 parts of tween-A,
3-7 parts of methyl benzoate,
3-7 parts of potassium sorbate,
20-40 parts of litharge powder.
2. The traditional Chinese medicine composition eye ointment for preventing and treating the myopia of the teenagers and the children, which is characterized by being prepared from a traditional Chinese medicine mixture and auxiliary materials in parts by weight:
63 parts of a Chinese medicinal mixture,
500 parts of auxiliary materials.
3. The traditional Chinese medicine composition eye ointment for preventing and treating the myopia of the teenagers and the children according to claim 1, wherein the traditional Chinese medicine mixture comprises the following raw materials in parts by weight:
9 parts of astragalus root,
9 parts of ginseng and the like,
6 parts of Chinese angelica root, the root of Chinese angelica,
6 parts of white paeony root,
6 parts of medlar, which is prepared from the following components,
6 parts of turmeric, namely, 6 parts of turmeric,
6 parts of wormwood herb,
3 parts of wild chrysanthemum flower,
3 parts of groundsel herb,
3 parts of green tangerine peel and the like,
3 parts of grassleaf sweelflag rhizome,
and 3 parts of pearl powder.
4. The traditional Chinese medicine composition eye ointment for preventing and treating the myopia of the teenagers of the children, which is characterized by comprising the following components in parts by weight:
100 parts of stearic acid, wherein the components are mixed,
50 parts of glycerin monostearate,
50 parts of liquid paraffin, and the like,
100 parts of white vaseline and the balance of the white vaseline,
50 parts of triethanolamine, and the components are mixed together,
100 parts of glycerin, and the total weight of the glycerin,
10 parts of tween-10, which is used for preparing the medicine,
5 parts of methyl benzoate and the total weight of the methyl benzoate,
5 parts of potassium sorbate, which are mixed together,
30 parts of litharge powder.
5. A method for preparing the traditional Chinese medicine composition eye ointment for preventing and treating the myopia of children and teenagers according to any one of claims 1-4, which is characterized by comprising the following steps:
(1) Preparing a traditional Chinese medicine composition water decoction filtrate: mixing radix astragali, ginseng radix, radix Angelicae sinensis, radix Paeoniae alba, fructus Lycii, curcuma rhizome, folium Artemisiae Argyi, flos Chrysanthemi Indici, herba Senecionis Scandentis, pericarpium Citri Reticulatae viride, and rhizoma Acori Graminei, decocting in water for 2 times (1 hr each time), mixing decoctions, and filtering with 400 mesh sieve to obtain Chinese medicinal decoction;
(2) Preparing myopia ointment: mixing stearic acid, glyceryl monostearate, liquid paraffin and white vaseline to obtain an oil phase, mixing the Chinese medicinal decoction, triethanolamine, glycerol, tween, methyl benzoate and potassium sorbate to obtain water phase, respectively heating the oil phase and water phase to 85deg.C in water, slowly pouring the oil phase into the water phase, stirring to obtain cream with milky yellow and semisolid, cooling the cream to 55deg.C, adding Margarita powder and Lithargyrum powder, and stirring for 2 hr until the cream is condensed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310245878.0A CN116211984B (en) | 2023-03-14 | 2023-03-14 | A Chinese medicinal composition eye ointment for preventing and treating myopia of children and teenagers, and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310245878.0A CN116211984B (en) | 2023-03-14 | 2023-03-14 | A Chinese medicinal composition eye ointment for preventing and treating myopia of children and teenagers, and its preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116211984A CN116211984A (en) | 2023-06-06 |
CN116211984B true CN116211984B (en) | 2024-02-09 |
Family
ID=86573024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310245878.0A Active CN116211984B (en) | 2023-03-14 | 2023-03-14 | A Chinese medicinal composition eye ointment for preventing and treating myopia of children and teenagers, and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116211984B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105031027A (en) * | 2015-06-22 | 2015-11-11 | 林润泓 | Chinese herbal medicine ointment for treating myopia |
CN112618660A (en) * | 2020-12-31 | 2021-04-09 | 林小冬 | Traditional Chinese medicine pearl eye ointment for nourishing blood and improving eyesight and preparation method thereof |
-
2023
- 2023-03-14 CN CN202310245878.0A patent/CN116211984B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105031027A (en) * | 2015-06-22 | 2015-11-11 | 林润泓 | Chinese herbal medicine ointment for treating myopia |
CN112618660A (en) * | 2020-12-31 | 2021-04-09 | 林小冬 | Traditional Chinese medicine pearl eye ointment for nourishing blood and improving eyesight and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
中医综合疗法治疗青少年近视临床观察;巨磊;光明中医;第30卷(第7期);1419-1421 * |
Also Published As
Publication number | Publication date |
---|---|
CN116211984A (en) | 2023-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101732506B (en) | External oculentum for treating amblyopia, astigmatism, strabismus, myopia and visual fatigue of teenagers | |
CN105434405A (en) | Eye-protection mask, and preparation method thereof | |
CN102357196B (en) | External traditional Chinese medicine composition for treating xerophthalmia and preparation method thereof | |
CN102362924B (en) | Medicinal composition for treating ophthalmic diseases and preparation method thereof | |
CN111035748A (en) | Traditional Chinese medicine composition for improving myopia, external application preparation for improving myopia and eye patch for improving myopia | |
CN112826900B (en) | Traditional Chinese medicine composition for treating seborrheic alopecia and pharmaceutical preparation thereof | |
CN108114084A (en) | It is a kind of to be used to improve Chinese medicine composition of eyesight and preparation method thereof | |
CN104971304A (en) | Xerophthalmia treatment medicine | |
CN112138046A (en) | Medicine composition for treating xerophthalmia and asthenopia and preparation method and application thereof | |
CN116211984B (en) | A Chinese medicinal composition eye ointment for preventing and treating myopia of children and teenagers, and its preparation method | |
CN112121104B (en) | Traditional Chinese medicine composition for relieving asthenopia and preventing and treating myopia | |
CN114010591B (en) | External traditional Chinese medicine gel ointment for treating asthenopia and preparation method thereof | |
CN105708936A (en) | Traditional Chinese medicinal composition for treating myopia, amblyopia and asthenopia | |
CN116115722B (en) | A Chinese medicinal eye ointment for preventing and treating hyperopia of children and teenagers, and its preparation method | |
CN113713022A (en) | Eye protection liquid and preparation method and application thereof | |
CN105012404B (en) | It is a kind of to be used to treat eye drops of scheroma and preparation method thereof | |
CN105902686A (en) | In-situ gel eyewash containing nano-carbon crystals and preparation method thereof | |
CN113663026A (en) | Traditional Chinese medicine eye-protecting liquid and preparation method thereof | |
CN110302357A (en) | A kind of external application eyesight-improving health care function Chinese medicine composition and preparation method thereof | |
CN110624086A (en) | Traditional Chinese medicine composition beneficial to improving eyesight and preparation method thereof | |
CN112336838A (en) | Traditional Chinese medicine formula eye drop for treating xerophthalmia and preparation method thereof | |
CN110522815A (en) | A kind of Chinese medicine composition and preparation method thereof for treating disease of eye | |
CN108498615A (en) | A kind of Chinese herb medicine eye health-care patch and preparation method thereof improving eyes based on nitric oxide principle | |
CN110227138A (en) | A kind of Chinese medicine external composition and preparation method thereof for eliminating vitreous opacity | |
CN106491730A (en) | A kind of treat Chinese medicine composition of glaucoma and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |